|
Réf
:
 Bourbeau
J et al. Randomised controlled trial of inhaled
corticosteroids in patients with chronic obstructive pulmonary disease. Thorax
1998;53:477-82
Burge
PS,
Calverley PMA, Jones PW, Spencer S, Anderson JA, Maslen TK on behalf
of the ISOLDE study investigators : Randomised, double blind, placebo
controlled study of fluticasone propionate in patients with moderate to
severe chronic obstructive pulmonary disease. The ISOLDE trial. BMJ 2000;320:1297-303
Pauwels
RA, Löfdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB,
Ohlsson SV. Long-term treatment with inhaled budesonide in persons with
mild chronic obstructive pulmonary disease who continue smoking. European
Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N
Engl J Med 1999;340:1948-53
Sin DD, Man
SFP. Inhaled
corticosteroids and survival in chronic obstructive pulmonary disease:
does the dose matter? Eur Respir J 2003;21:260-6
Société de Pneumologie de Langue Française.
Actualisation des recommandations pour la prise en
charge de la BPCO. Rev Mal Resp 2003;20:294-9
Vestbo
J,
Sorensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of
inhaled budesonide in mild and moderate chronic obstructive pulmonary
disease: a randomised controlled trial. Lancet, 1999;353:1819-23
|
La 
